Last updated: March 19, 2026

Hypothyroidism is a deficiency of the thyroid hormones T3 and T4. The presentation of hypothyroidism can be subtle and non-specific since almost all cell nuclei have thyroid receptors, which affect various metabolic processes. Prognosis is good if treated, but it can be disastrous if left untreated.

Hypothyroidism is common, affecting 4 per 1000 individuals per year.

The most common cause of hypothyroidism is Hashimoto’s thyroiditis.

Classification of Hypothyroidism

ClassificationDescriptionCausesLab findings
Primary hypothyroidismDecreased production of thyroid hormone from the thyroid glandHashimoto thyroiditis, drug-induced hypothyroidism, thyroiditis, iatrogenic (post-RAI ablation), iodine deficiency, congenital (dysplasia or aplasia)High TSH, low T3 and T4
Primary autoimmunePrimary atrophic hypothyroidism (due to diffuse lymphocytic infiltration), Hashimoto’s thyroiditis
Drug-inducedAntithyroid drugs, amiodarone, lithium, iodine
IatrogenicPost-thyroidectomy, post-radioiodine ablation
Subacute thyroiditisTemporary hypothyroidism after a hypothyroid state
Iodine deficiencyThe most common cause worldwide
Secondary hypothyroidismDecreased thyroid hormone due to decreased TSH (hypopituitarism). Very rareTumor, mass effectLow TSH, low T3 and T4
Tertiary hypothyroidismDecreased thyroid hormone due to decreased TRH. Very rareTumor, mass effectLow TSH, low T3 and T4

Signs and symptoms of hypothyroidism

ClassificationSigns and symptoms
Reduced metabolic rateFatigue, cold intolerance, weight gain despite reduced appetite, constipation, bradycardia, decreased deep tendon reflexes, hair loss
Increased stimulationPainless goitre
Increased TRHHyperprolactinemia, menorrhagia, amenorrhoea, galactorrhoea
Deposition of glycosaminoglycansMyxoedema (non-pitting oedema), hoarseness, pretibial and periorbital oedema
PsychiatricDepression, pseudodementia (older individuals), impaired memory or cognition
  • Associated conditions
    • Type 1 diabetes mellitus
    • Addison’s disease
    • Turner’s and Down’s syndrome
    • Cystic fibrosis
    • Primary biliary cholangitis
    • Ovarian hyperstimulation
    • POEMS syndrome (Polyneuropathy, organomegaly, endocrinopathy, M-protein band)
    • Dyshormonogenesis, e.g Pendred’s syndrome
  • Signs and symptoms
    • Fatigue (most common complaint)
    • Cold intolerance
    • Weight gain
    • Reduced appetite
    • Constipation
    • Hair loss
    • Painless goitre
    • Menstrual cycle abnormalities
    • Pretibial and periorbital oedema
    • Depression
    • Pseudodementia
    • Reduced memory
  • Physical examination (BRADYCARDIC)
    • Bradycardia
    • Reflexes reduced
    • Ataxia (cerebellar)
    • Dry-thin hair or skin
    • Yawning, drowsy or coma
    • Cold peripheries due to reduced temperature
    • Ascites +/- non-pitting oedema +/- pericarial or pleural effusion
    • Round puffy face or obese
    • Defeated demeanour
    • Immobile +/- Ileus
    • Congestive heart failure
  • Differentials
  • Investigations
    • Complete blood count to rule out anaemia as a cause of fatigue
      • Normocytic anaemia may be present in hypothyroidism
      • Microcytic anaemia may be present in women with hypothyroidism
    • Serum TSH levels
      • Elevated TSH is seen in primary hypothyroidism
    • Serum T3 and T4
    • Serum Thyroglobulin (Tg) and anti-thyroglobulin Antibody (TgAb) tests to identify autoimmune thyroid disease
    • Serum Thyrotropin Receptor Antibodies (TRAb) test to rule out Graves’ disease
    • Ultrasound or nuclear scan if a goitre or nodule is present
  • Treatment
    • Daily Levothyroxine (T4)
      • Start at a lower dose in elderly patients or those with ischaemic heart disease (may precipitate angina or MI), e.g. 25 mcg
      • Other patients can be started at 50 – 100 mcg
      • Review at 12 weeks
      • Adjust 6-weekly by clinical state and normalise TSH (0.5 – 2.5 mU/L)
      • Increase dose by 25 – 50 ug in pregnant women and monitor TSH (while aiming for lower values)
  • Side effects of levothyroxine
    • Hyperthyroidism (over-treatment)
    • Reduced bone mineral density
    • Worsening of angina
    • Atrial fibrillation
    • Levothyroxine also interacts with iron absorption and should be given at least 2 hours apart
  • Complications of hypothyroidism
  • Complications of hypothyroidism in pregnancy
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *